Genomictree Inc. (228760) — Financial Flexibility Index
Genomictree Inc. (228760) has a Financial Flexibility Index of -0.58x as of December 2025. Free cash flow of ₩-3.15 Billion (operating CF ₩-3.21 Billion minus capex ₩62.29 Million) represents -1% of total liabilities (₩5.45 Billion). Also explore how fast is Genomictree Inc. growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Genomictree Inc. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Genomictree Inc. across 6 annual periods. Check 228760 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Genomictree Inc. (2020–2025)
Year-by-year free cash flow to debt coverage for Genomictree Inc.. For the full company profile including market capitalisation, see Genomictree Inc. (228760) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.37x | ₩-7.45 Billion | ₩-10.19 Billion | ₩5.45 Billion | ▲ +21.7% |
| 2024 | -1.74x | ₩-11.08 Billion | ₩-13.63 Billion | ₩6.36 Billion | ▼ -28.6% |
| 2023 | -1.36x | ₩-10.59 Billion | ₩-10.88 Billion | ₩7.81 Billion | ▼ -1339.5% |
| 2022 | 0.11x | ₩6.11 Billion | ₩4.29 Billion | ₩55.86 Billion | ▲ +61.7% |
| 2021 | 0.07x | ₩4.20 Billion | ₩-7.63 Billion | ₩62.05 Billion | ▲ +120.4% |
| 2020 | -0.33x | ₩-7.50 Billion | ₩-10.19 Billion | ₩22.64 Billion | — |